Health Update Bahamas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Update Bahamas.

September 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Press releases published on September 9, 2025

September 9, 2025

24/7 Market News: Ken Le, Not Stan Lee, to Lead Prodigy Silk’s Super Fiber Deliveries to Global Brands for Kraig Labs

GlobeNewswire

September 9, 2025

HCW Biologics Reports Positive Results from Non-Human Primate Study for Its Proprietary Second-Generation T-Cell Engager Program

GlobeNewswire

September 9, 2025

Numab Therapeutics Announces Leadership Transition and Appoints Angehrn Pavik as Chief Executive Officer

GlobeNewswire

September 9, 2025

Hydrafacial Launches Inaugural Hydrafacial Advisory Councils & Ambassador Network to Fuel Next-Era Innovation and Growth

GlobeNewswire

September 9, 2025

American Oncology Network and Low Country Cancer Care Welcome Dr. Anton Juncaj

GlobeNewswire

September 9, 2025

Arrivent Presents the Final Analysis of Firmonertinib Monotherapy Data from Global Phase 1b Study in EGFR PACC Mutant Non-Small Cell Lung Cancer at the 2025 World Conference on Lung Cancer

GlobeNewswire

September 9, 2025

Hyperion DeFi Strengthens Leadership Team With Key Appointments to Accelerate DeFi Strategy

GlobeNewswire

September 9, 2025

Peer Leadership and Resilience Shine in Military Veteran Alpine Challenge

GlobeNewswire

September 9, 2025

Salarius Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement

GlobeNewswire

September 9, 2025

Enlivex Announces Issuance of New Patent Application Covering the Use of Allocetra in Patients with Osteoarthritis

GlobeNewswire

September 9, 2025

Sutter Health Named Among Top 5 Best Workplaces for Innovators by Fast Company

GlobeNewswire

September 9, 2025

Aveanna to Participate at the Jefferies Healthcare Services Conference

GlobeNewswire

September 9, 2025

Anavex Life Sciences Announces Oral Blarcamesine Cognitive Resilience Results Approximating Normal Aging in New Precision Medicine Clinical Data from Phase IIb/III Alzheimer’s Disease Trial

GlobeNewswire

September 9, 2025

MAPS Board of Directors Names Betty Aldworth and Ismail Lourido Ali as Co-Executive Directors

GlobeNewswire

September 9, 2025

Xilio Therapeutics Announces Initiation of Phase 2 Trial for Efarindodekin Alfa (XTX301), a Tumor-Activated IL-12, and Achievement of $17.5 Million Development Milestone Under Exclusive License Agreement with Gilead

GlobeNewswire

September 9, 2025

Emergent BioSolutions Receives New Contract Modification for ACAM2000®, (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government, Further Demonstrating Importance of Public Health Preparedness

GlobeNewswire

September 9, 2025

Appili Therapeutics to Present Progress on Tularemia Biodefense Vaccine at NATO CBRN Conference

GlobeNewswire

September 9, 2025

Sight Sciences Announces the OMNI® Surgical System to be Included in UnitedHealthcare’s® Expanded Coverage of Glaucoma Surgical Treatments

GlobeNewswire

September 9, 2025

Libtayo® (cemiplimab) Plus Chemotherapy Results at Five Years Reinforce Significant and Durable Improvements in Survival Outcomes for Advanced Non-small Cell Lung Cancer

GlobeNewswire

September 9, 2025

Aclaris Therapeutics Announces Late-Breaking Abstract and Oral Presentation On ATI-2138 Phase 2a Results at the 2025 European Academy of Dermatology and Venereology (EADV) Congress

GlobeNewswire